Kirtland Hills Capital Management’s Boston Scientific BSX Stock Holding History

Kirtland Hills Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$633K	Sell	9,800 -639	-6%	-$51.1K	0.2%	106
2025 Q4	$995K	Hold	10,439	–	–	0.35%	76
2025 Q3	$1.02M	Sell	10,439 -65	-0.6%	-$6.73K	0.4%	70
2025 Q2	$1.13M	Hold	10,504	–	–	0.52%	62
2025 Q1	$999K	Buy	10,504 +261	+3%	+$26.3K	0.61%	53
2024 Q4	$915K	Buy	10,243 +266	+3%	+$23.4K	0.59%	61
2024 Q3	$836K	Hold	9,977	–	–	0.46%	64
2024 Q2	$768K	Hold	9,977	–	–	0.64%	57
2024 Q1	$729K	Buy	+9,977	New	+$641K	0.63%	58

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kirtland Hills Capital Management's BSX Position: Q1 2026 in Review

Kirtland Hills Capital Management reduced its Boston Scientific (BSX) stake by 6.1% in Q1 2026, selling an estimated $51.1K and leaving 9,800 shares worth $633K. The position accounts for 0.2% of the portfolio, ranked #106.

Kirtland Hills Capital Management first reported a position in BSX in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.13M in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Kirtland Hills Capital Management held 9,800 shares of Boston Scientific worth $633K as of Q1 2026.
Kirtland Hills Capital Management sold 639 Boston Scientific shares in Q1 2026, an estimated $51.1K.
Boston Scientific made up 0.2% of Kirtland Hills Capital Management's portfolio in Q1 2026, its #106 holding.
Kirtland Hills Capital Management first reported a position in Boston Scientific in Q1 2024 and has held it in 9 quarters since.
Kirtland Hills Capital Management's Boston Scientific position peaked at $1.13M in Q2 2025.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Kirtland Hills Capital Management's 13F filing for Q1 2026, filed 13 May 2026.